TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9342133

Group type: EXPERIMENTAL
Intervention: Esmolol pretreatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: No esmolol pretreatment (Control)
Number of subjects: 18
Study: 8441428

Group type: EXPERIMENTAL
Intervention: Low-dose unilateral electroconvulsive therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-dose unilateral electroconvulsive therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low-dose bilateral electroconvulsive therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-dose bilateral electroconvulsive therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Combined bilateral groups
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bilateral therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 96

Group type: COMPARATOR
Intervention: Patients who responded to therapy
Number of subjects: 96
Study: 3954009

Group type: EXPERIMENTAL
Intervention: Reflective blanket and heated glycine 1.5% bladder irrigation solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: No reflective blanket and/or heated 1.5% glycine
Number of subjects: 100
Study: 30321510

Group type: EXPERIMENTAL
Intervention: Nebulized Tranexamic Acid (500 mg tid)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 47
Study: 27676118

Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 24452705

Group type: EXPERIMENTAL
Intervention: Group memory rehabilitation programme (ten 1.5-hour sessions)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 48
Study: 22588495

Group type: COMPARATOR
Intervention: 20mg of Methylphenidate (MPH)
Number of subjects: 29
Study: 21280534

Group type: EXPERIMENTAL
Intervention: 0.2 mg/ml Mitomycin-C solution
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal Saline Solution
Number of subjects: 48

Group type: COMPARATOR
Intervention: 3% Sodium Chloride
Number of subjects: 48
Study: 17591527

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug therapy (including ACE inhibitors and ARBs)
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: Cohort Study participants
Number of subjects: 691

Group type: COMPARATOR
Intervention: Individuals who declined to participate in the Cohort Study
Number of subjects: 691
Study: 16318141

Group type: EXPERIMENTAL
Intervention: Acupuncture group I (Jianji and Shenshu acupoints)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture group II (acupoints at limbs)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 12175313

Group type: EXPERIMENTAL
Intervention: EMF exposure (900 MHz, pulsed with 217 Hz, 2 W)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo exposure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EMF exposure
Number of subjects: 40
Study: 10221703

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (30 microg of ethinyl oestradiol and 0.15 mg of levonorgestrel per tablet)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 8595506

Group type: EXPERIMENTAL
Intervention: AZT monotherapy
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: AZT/ddI and AZT/ddC combination therapy
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: AZT/3TC combination therapy
Number of subjects: 2
Study: 2242846

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (160 mg daily for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 1233231

Group type: EXPERIMENTAL
Intervention: Diazepam 20 mg i.m. followed by diazepam 20 mg i.v.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg i.m. followed by diazepam 20 mg i.v.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pentobarbitone 1 mg/kg i.m. followed by i.v. saline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg and saline i.v.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Diazepam 20 mg i.v.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Unsatisfactory premedication
Number of subjects: 32
Study: 30856340

Group type: EXPERIMENTAL
Intervention: Lower body resistance training (RT) for 2 weeks (6 sessions) including leg press, leg curl, and leg extension exercises
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 28723227

Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine (mean final daily dose of 2.6 ± 1.1 mg, n=14)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (n=18)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 25222798

Group type: EXPERIMENTAL
Intervention: Gratitude intervention (writing work-related gratitude diaries twice a week for 4 weeks)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Hassle intervention (writing work-related hassle diaries twice a week for 4 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Nil-treatment (no-diary group)
Number of subjects: 102
Study: 23802638

Group type: EXPERIMENTAL
Intervention: Sixth-generation dental bonding agents (DBAs)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Seventh-generation dental bonding agents (DBAs)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Fourth-generation dental bonding agents (DBAs)
Number of subjects: 108
Study: 21561960

Group type: EXPERIMENTAL
Intervention: Teleconference-delivered fatigue management program
Number of subjects: 190

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 190
Study: 17555901

Group type: EXPERIMENTAL
Intervention: Standard dose Gd‐BOPTA (0.05 mmol/kg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Gd‐BOPTA (0.1 mmol/kg)
Number of subjects: 47
Study: 17056961

Group type: EXPERIMENTAL
Intervention: Scalp nerve block (SNB) with 10 mL of 0.9% saline and a 1:1 mixture of bupivacaine 0.5% and lidocaine 2%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Morphine 0.1 mg x kg(‐1) IV after dural closure
Number of subjects: 50
Study: 14616449

Group type: EXPERIMENTAL
Intervention: Serum IGF‐1 levels
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Serum IGFBP‐3 levels
Number of subjects: 652
Study: 11099280

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole)
Number of subjects: 12649

Group type: COMPARATOR
Intervention: Conventional antipsychotics (usually haloperidol or chlorpromazine)
Number of subjects: 12649
Study: 8820712

Group type: EXPERIMENTAL
Intervention: Knowledge of derivational suffixes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suffix productivity
Number of subjects: 0
Study: 1479417

Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg daily for one week (Group A)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg daily for two weeks (Group B)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study: 6231893

Group type: EXPERIMENTAL
Intervention: Azapropazone 600 mg b.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg b.d.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 31570180

Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Number of subjects: 79

Group type: COMPARATOR
Intervention: Non-supplemented group
Number of subjects: 79
Study: 29394919

Group type: EXPERIMENTAL
Intervention: TAU + iERT (N=100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: TAU only (N=100)
Number of subjects: 200
Study: 27270841

Group type: EXPERIMENTAL
Intervention: Heat therapy (40.5°C bath for 60 min/session, 4-5 times/week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham group (thermoneutral water immersion)
Number of subjects: 20
Study: 25073732

Group type: EXPERIMENTAL
Intervention: Difficult anagram task
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Cold pressor task
Number of subjects: 91

Group type: COMPARATOR
Intervention: Easy anagram task
Number of subjects: 91
Study: 22929458

Group type: EXPERIMENTAL
Intervention: Life! programme intervention group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 92
Study: 19897338

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention with a cognitive behavioral orientation (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention with community stakeholders (n=22)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting list control (n=18)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 60
Study: 16555259

Group type: EXPERIMENTAL
Intervention: 3T MRI
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 3T multislice DIR PD-/T2-weighted images
Number of subjects: 7

Group type: COMPARATOR
Intervention: 1.5T MRI
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 1.5T and 3T MRI
Number of subjects: 7
Study: 12665974

Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (HH)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normobaric hypoxia (NH)
Number of subjects: 18
Study: 11191004

Group type: EXPERIMENTAL
Intervention: 0.05% azelastine eye drops
Number of subjects: 307

Group type: COMPARATOR
Intervention: 0.05% levocabastine eye drops
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study: 9169209

Group type: EXPERIMENTAL
Intervention: Normative measures for 400 line drawings
Number of subjects: 400
Study: 1468261

Group type: EXPERIMENTAL
Intervention: Once daily application of betamethasone dipropionate cream and either a water-in-oil based moisturizing cream or lotion
Number of subjects: 96

Group type: COMPARATOR
Intervention: Twice daily application of betamethasone dipropionate cream
Number of subjects: 96
Study: 4028806

Group type: EXPERIMENTAL
Intervention: Ketoprofen suppositories (2 X 100 mg) administered 1-hour pre-operatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo suppositories administered 1-hour pre-operatively
Number of subjects: 60
Study: 30674296

Group type: EXPERIMENTAL
Intervention: Topical microporous polysaccharide hemospheres (MPH) applied to the surgical site
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no MPH application)
Number of subjects: 42
Study: 29544694

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 25862566

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Distal gastrectomy
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Age (75 years or older)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Age (younger than 75 years)
Number of subjects: 685
Study: 23238910

Group type: EXPERIMENTAL
Intervention: Crisis plans facilitated by patient advocates (PACP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crisis plans drawn up by clinicians (CCP)
Number of subjects: 0
Study: 22227184

Group type: EXPERIMENTAL
Intervention: Dietary intake of antioxidants in CKD patients
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Oxidative stress measured in blood
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Micronutrient monitoring
Number of subjects: 185
Study: 19809786

Group type: COMPARATOR
Intervention: Gamma Knife Model 4C (group 4C)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Gamma Knife Perfexion (group P2)
Number of subjects: 78
Study: 17600880

Group type: COMPARATOR
Intervention: Cisplatin and etoposide with ondansetron and metoclopramide
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cisplatin and etoposide with ondansetron, metoclopramide plus dexamethasone 8 mg i.v. per day for 3 days
Number of subjects: 60
Study: 17249630

Group type: EXPERIMENTAL
Intervention: DSM-IV model for classifying depressive disorders
Number of subjects: 0
Study: 12746908

Group type: EXPERIMENTAL
Intervention: Active lupus nephritis patients
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Inactive lupus disease patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Parapemphigus controls
Number of subjects: 45

Group type: COMPARATOR
Intervention: Diabetes controls
Number of subjects: 45
Study: 10891035

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8929200

Group type: EXPERIMENTAL
Intervention: 2.5% CO2 exposure
Number of subjects: 10
Study: 1530141

Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg, 160 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg, 20 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 4004014

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 16

Group type: COMPARATOR
Intervention: No acetazolamide (Control)
Number of subjects: 16
Study: 30084949

Group type: EXPERIMENTAL
Intervention: Stepped wedge design (SWD) intervention for post-partum intra-uterine device insertion services
Number of subjects: 0
Study: 29774635

Group type: EXPERIMENTAL
Intervention: Aripiprazole 2 mg/day
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Aripiprazole 6-12 mg/day
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Aripiprazole 24-30 mg/day
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Aripiprazole (OLE, initial dose: 2 mg/day, maintenance dose: 6-24 mg/day, max 30 mg/day)
Number of subjects: 135
Study: 26571136

Group type: EXPERIMENTAL
Intervention: Zumba® fitness (1 to 2 classes of 1 hour weekly)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maintenance of habitual activity (control group)
Number of subjects: 20
Study: 23867053

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 66

Group type: COMPARATOR
Intervention: Psychosocial intervention
Number of subjects: 66
Study: 22853755

Group type: EXPERIMENTAL
Intervention: V-5 Immunitor™ (V5)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 20538830

Group type: EXPERIMENTAL
Intervention: Bachmann's bundle pacing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Right atrial appendage pacing
Number of subjects: 30
Study: 18675745

Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Number of subjects: 28

Group type: COMPARATOR
Intervention: Superficial cervical plexus block plus general anesthesia
Number of subjects: 28
Study: 15902992

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g/d for 5 days)
Number of subjects: 18
Study: 14602495

Group type: EXPERIMENTAL
Intervention: Radical surgery followed by post-operative radiation therapy (Sx+PORT) (Arm I)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Radical radiation therapy followed by salvage surgery (RRT+/‐SSx) (Arm II)
Number of subjects: 72
Study: 10485502

Group type: EXPERIMENTAL
Intervention: DFP 25 mg
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DFP 50 mg
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 550 mg
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 8734768

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) at doses of 0.015, 0.25, 1.0, 2.0 micrograms/kg/min for 20 min each
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1744874

Group type: EXPERIMENTAL
Intervention: 2% polynoxylin powder applied daily to the groin and external genitalia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 100
Study: 6803377

Group type: EXPERIMENTAL
Intervention: Topical antibiotics (neomycin and polymyxin)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Topical antibiotics (neomycin and polymyxin) plus systemic antibiotics (gentamicin and penicillin)
Number of subjects: 54
Study: 28797212

Group type: EXPERIMENTAL
Intervention: Errorless Learning (EL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Trial-and-Error Learning (TEL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Conceptual cues
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lexical cues
Number of subjects: 24
Study: 27519933

Group type: EXPERIMENTAL
Intervention: 0.5% tropicamide and 5% phenylephrine eyedrops (PTT regimen)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% tropicamide eyedrops (TTT regimen)
Number of subjects: 30
Study: 26598195

Group type: EXPERIMENTAL
Intervention: EDTA pretreatment followed by self-etching resin adhesive
Number of subjects: 12

Group type: COMPARATOR
Intervention: Self-etching resin adhesive only (Control)
Number of subjects: 12
Study: 23010696

Group type: EXPERIMENTAL
Intervention: Basic Internet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced Internet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced Internet+Phone
Number of subjects: 0
Study: 21463114

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance (one weekly injection for 4 weeks)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 269
Study: 18645555

Group type: EXPERIMENTAL
Intervention: With dressing (dressing change and re-application every two days)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Without dressing (wound left open after first dressing change at 48 hours)
Number of subjects: 102
Study: 16278926

Group type: EXPERIMENTAL
Intervention: Azantac
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Midaven
Number of subjects: 25
Study: 12782431

Group type: EXPERIMENTAL
Intervention: rHuEPO 10,000 U three times weekly
Number of subjects: 122

Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 122
Study: 10634391

Group type: EXPERIMENTAL
Intervention: Men during exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Women during exercise
Number of subjects: 16
Study: 9471024

Group type: EXPERIMENTAL
Intervention: O1COr (Omeprazole 20 mg once daily + Clarithromycin 250 mg twice daily + Ornidazole 500 mg twice daily)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: OCOr (Omeprazole 20 mg twice daily + Clarithromycin 250 mg twice daily + Ornidazole 500 mg twice daily)
Number of subjects: 203

Group type: COMPARATOR
Intervention: OCM (Omeprazole 20 mg twice daily + Clarithromycin 250 mg twice daily + Metronidazole 500 mg twice daily)
Number of subjects: 203
Study: 1610161

Group type: EXPERIMENTAL
Intervention: Rice Bubbles (0.5 g/kg body weight)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sustain (0.5 g/kg body weight)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All‐Bran (0.5 g/kg body weight)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Porridge (0.5 g/kg body weight)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: White bread (0.5 g/kg body weight)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Egg and bacon meal (0.5 g protein/kg body weight)
Number of subjects: 7
Study: 3884747

Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (greater than 100 mg/m2) by an eight-hour infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-dose cisplatin (greater than 100 mg/m2) by a one-hour infusion
Number of subjects: 20
Study: 31103608

Group type: EXPERIMENTAL
Intervention: Metreleptin administration (replacement doses)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Metreleptin administration (escalating doses)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (hypoleptinemic state)
Number of subjects: 29
Study: 29349511

Group type: EXPERIMENTAL
Intervention: iPAPD+SRP
Number of subjects: 24

Group type: COMPARATOR
Intervention: sham-treatment+SRP
Number of subjects: 24
Study: 26406219

Group type: EXPERIMENTAL
Intervention: Cervical stabilization exercise (5 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 26225780

Group type: EXPERIMENTAL
Intervention: 0.1% Nepafenac
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.4% Ketorolac Tromethamine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 0.1% Nepafenac (Diabetic subgroup)
Number of subjects: 200
Study: 24125085

Group type: EXPERIMENTAL
Intervention: Trauma-focused condition (n = 45)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Experimental sexual schema-focused condition (n = 37)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control condition (n = 42)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Overall dropout rate
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Predictors of dropout
Number of subjects: 124
Study: 21172477

Group type: EXPERIMENTAL
Intervention: Minimized cardiopulmonary bypass (MCPB)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation (CCPB)
Number of subjects: 37
Study: 19088658

Group type: EXPERIMENTAL
Intervention: Virtual ED
Number of subjects: 30

Group type: COMPARATOR
Intervention: PS
Number of subjects: 30
Study: 16563329

Group type: EXPERIMENTAL
Intervention: Rapiscope
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chest auscultation
Number of subjects: 40
Study: 12467721

Group type: EXPERIMENTAL
Intervention: New irregularity index algorithm
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clinical evaluation by dermatologists
Number of subjects: 40
Study: 11460456

Group type: EXPERIMENTAL
Intervention: Extended ambulatory physiotherapy (EAP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Regular physiotherapy (PT)
Number of subjects: 35
Study: 9676677

Group type: EXPERIMENTAL
Intervention: Specific instructions about abstract accuracy (intervention group)
Number of subjects: 250

Group type: COMPARATOR
Intervention: No specific instructions (control group)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Overall comparison of defects
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Defective abstracts analysis
Number of subjects: 250
Study: 7973228

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 3131794

Group type: EXPERIMENTAL
Intervention: Arginine-vasopressin (AVP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31230964

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) (45 L/min, FIO2 100%)
Number of subjects: 90

Group type: COMPARATOR
Intervention: High-Flow Face Mask (HFFM) (15 L/min)
Number of subjects: 90